TNF-related apoptosis-inducing ligand-induced apoptosis of melanoma is associated with changes in mitochondrial membrane potential and perinuclear clustering of mitochondria

被引:97
作者
Thomas, WD [1 ]
Zhang, XD [1 ]
Franco, AV [1 ]
Nguyen, T [1 ]
Hersey, P [1 ]
机构
[1] Dept Oncol & Immunol, Newcastle, NSW 2300, Australia
关键词
D O I
10.4049/jimmunol.165.10.5612
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Past studies have shown that TNF-related apoptosis-inducing ligand (TRAIL) induced apoptosis in a high proportion of cultured melanoma by caspase-dependent mechanisms. In the present studies we have examined whether TRAIL-induced apoptosis of melanoma was mediated by direct activation of effector caspases or whether apoptosis was dependent on changes in mitochondrial membrane potential (MR IP) and mitochondrial-dependent pathways of apoptosis, Changes in MMP were measured by fluorescent emission from rhodamine 123 in mitochondria, TRAIL, but not TNF-alpha or Fas ligand, was shown to induce marked changes In MMP in melanoma, which showed a high correlation with TRAIL-induced apoptosis, This was associated with activation of proapoptotic protein Bid and release of cytochrome c into the cytosol, Overexpression of B cell lymphoma gene 2 (Bcl-2) inhibited TRAIL-induced release of cytochrome c, changes in MMP, and apoptosis, The pan caspase inhibitor z-Val-Ala-Asp-fluoromethylketone (zVAD-fmk) and the inhibitor of caspase-8 (z-Ile-Glu-Thr-Asp-fluoromethglketone; zIETD-fmk) blocked changes in MMP and apoptosis, suggesting that the changes in MMP were dependent on activation of caspase-8, Activation of caspase-9 also appeared necessary for TRAIL-induced apoptosis of melanoma, In addition, TRAIL, but not TNF-alpha or Fas ligand, was shown to induce clustering of mitochondria around the nucleus. This process was not essential for apoptosis but appeared to increase the rate of apoptosis, Taken together, these results suggest that TRAIL induces apoptosis of melanoma tells by recruitment of mitochondrial pathways to apoptosis that are dependent on activation of caspase-8, Therefore, factors that regulate the mitochondrial pathway may be important determinants of TRAIL-induced apoptosis of melanoma.
引用
收藏
页码:5612 / 5620
页数:9
相关论文
共 48 条
[1]   Safety and antitumor activity of recombinant soluble Apo2 ligand [J].
Ashkenazi, A ;
Pai, RC ;
Fong, S ;
Leung, S ;
Lawrence, DA ;
Masters, SA ;
Blackie, C ;
Chang, L ;
McMurtrey, AE ;
Hebert, A ;
DeForge, L ;
Koumenis, IL ;
Lewis, D ;
Harris, L ;
Bussiere, J ;
Koeppen, H ;
Shahrokh, Z ;
Schwall, RH .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) :155-162
[2]  
CORY S, 1999, CANCER RES, V59, P1685
[3]   Polymerase chain reaction detection of melanoma cells in the circulation: Relation to clinical stage, surgical treatment, and recurrence from melanoma [J].
Curry, BJ ;
Myers, K ;
Hersey, P .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (05) :1760-1769
[4]   The 55-kDa tumor necrosis factor receptor induces clustering of mitochondria through its membrane-proximal region [J].
De Vos, K ;
Goossens, V ;
Boone, E ;
Vercammen, D ;
Vancompernolle, K ;
Vandenabeele, P ;
Haegeman, G ;
Fiers, W ;
Grooten, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (16) :9673-9680
[5]   IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases [J].
Deveraux, QL ;
Roy, N ;
Stennicke, HR ;
Van Arsdale, T ;
Zhou, Q ;
Srinivasula, SM ;
Alnemri, ES ;
Salvesen, GS ;
Reed, JC .
EMBO JOURNAL, 1998, 17 (08) :2215-2223
[6]   Apoptosis - A cellular poison cupboard [J].
Earnshaw, WC .
NATURE, 1999, 397 (6718) :387-+
[7]   Bcl-2 and mitochondrial oxygen radicals - New approaches with reactive oxygen species-sensitive probes [J].
Esposti, MD ;
Hatzinisiriou, I ;
McLennan, H ;
Ralph, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (42) :29831-29837
[8]   Inhibition of human caspases by peptide-based and macromolecular inhibitors [J].
Garcia-Calvo, M ;
Peterson, EP ;
Leiting, B ;
Ruel, R ;
Nicholson, DW ;
Thornberry, NA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (49) :32608-32613
[9]  
Griffith TS, 1998, J IMMUNOL, V161, P2833
[10]  
Griffith TS, 1999, J IMMUNOL, V162, P2597